Orphalan Drug Patent Portfolio
Orphalan owns 1 orange book drug protected by 2 US patents Given below is the list of Orphalan's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10988436 | Crystalline form of triethylenetetramine tetrahydrochloride and its pharmaceutical use | 03 May, 2039 | Active |
| US11072577 | Crystalline form of triethylenetetramine tetrahydrochloride and its pharmaceutical use | 03 May, 2039 | Active |
Latest Legal Activities on Orphalan's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Orphalan.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Post Issue Communication - Certificate of Correction | 31 Aug, 2021 | US11072577 |
|
Email Notification
Critical
| 26 Aug, 2021 | US11072577 |
| Mail Certificate of Correction Memo | 25 Aug, 2021 | US11072577 |
| Certificate of Correction Memo | 24 Aug, 2021 | US11072577 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 27 Jul, 2021 | US11072577 |
|
Recordation of Patent Grant Mailed
Critical
| 27 Jul, 2021 | US11072577 |
|
Email Notification
Critical
| 08 Jul, 2021 | US11072577 |
|
Issue Notification Mailed
Critical
| 07 Jul, 2021 | US11072577 |
|
Email Notification
Critical
| 25 Jun, 2021 | US11072577 |
|
Application ready for PDX access by participating foreign offices
Critical
| 24 Jun, 2021 | US11072577 |
|
PG-Pub Issue Notification
Critical
| 24 Jun, 2021 | US11072577 |
| Dispatch to FDC | 23 Jun, 2021 | US11072577 |
|
Application Is Considered Ready for Issue
Critical
| 23 Jun, 2021 | US11072577 |
|
Issue Fee Payment Verified
Critical
| 21 Jun, 2021 | US11072577 |
|
Issue Fee Payment Received
Critical
| 21 Jun, 2021 | US11072577 |
Orphalan's Family Patents
Orphalan Drug List
Given below is the complete list of Orphalan's drugs and the patents protecting them.
1. Cuvrior
Cuvrior is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10988436 | Crystalline form of triethylenetetramine tetrahydrochloride and its pharmaceutical use |
03 May, 2039
(14 years from now)
| Active |
| US11072577 | Crystalline form of triethylenetetramine tetrahydrochloride and its pharmaceutical use |
03 May, 2039
(14 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Cuvrior's drug page